메뉴 건너뛰기




Volumn 123, Issue 3, 2003, Pages 496-501

Factor V I359T: A novel mutation associated with thrombosis and resistance to activated protein C

Author keywords

Activated protein C resistance; Factor V; Mutation; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

EID: 0242329725     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04624.x     Document Type: Article
Times cited : (49)

References (21)
  • 1
    • 0031612929 scopus 로고    scopus 로고
    • Recommendations for a nomenclature system for human gene mutations
    • Nomenclature Working Group.
    • Antonarakis, S.E. (1998) Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Human Mutatation. 11, 1-3.
    • (1998) Human Mutatation , vol.11 , pp. 1-3
    • Antonarakis, S.E.1
  • 2
    • 0028106062 scopus 로고
    • High prevalence of a mutation in the factor V gene within the UK population: Relationship top activated protein C resistance and familial thrombosis
    • Beauchamp, N.J., Daly, M.E., Hampton, K.K., Cooper, P.C., Preston, F.E. & Peake, I.R. (1994) High prevalence of a mutation in the factor V gene within the UK population: relationship top activated protein C resistance and familial thrombosis. British Journal of Haematology. 88, 219-222.
    • (1994) British Journal of Haematology. , vol.88 , pp. 219-222
    • Beauchamp, N.J.1    Daly, M.E.2    Hampton, K.K.3    Cooper, P.C.4    Preston, F.E.5    Peake, I.R.6
  • 5
    • 0031757205 scopus 로고    scopus 로고
    • Molecular bases of pseudo-homozygous APC resistance: The compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma
    • Castoldi, E., Kalafatis, M., Lunghi, B., Simioni, P., Ioannou, PA., Petio, M., Girolami, M., Mann, A., K.G. & Bernardi, F. (1998) Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma. Thrombosis and Haemostasis, 80, 403-406.
    • (1998) Thrombosis and Haemostasis , vol.80 , pp. 403-406
    • Castoldi, E.1    Kalafatis, M.2    Lunghi, B.3    Simioni, P.4    Ioannou, P.A.5    Petio, M.6    Girolami, M.7    Mann, A.8    Bernardi, F.9
  • 6
    • 0027446268 scopus 로고
    • Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
    • Dahlback, B., Carlsson, M. & Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Acadamic Sciences USA, 90, 1004-1008.
    • (1993) Proceedings of the National Acadamic Sciences USA , vol.90 , pp. 1004-1008
    • Dahlback, B.1    Carlsson, M.2    Svensson, P.J.3
  • 7
    • 1842326190 scopus 로고    scopus 로고
    • The carbohydrate moiety of factor V modulates inactivation by activated protein C
    • Fernandez, J.A., Hackeng, T.M., Kojima, K. & Griffin, J.H. (1997) The carbohydrate moiety of factor V modulates inactivation by activated protein C. Blood, 89, 4348-4354.
    • (1997) Blood , vol.89 , pp. 4348-4354
    • Fernandez, J.A.1    Hackeng, T.M.2    Kojima, K.3    Griffin, J.H.4
  • 8
    • 0031058324 scopus 로고    scopus 로고
    • Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance
    • Guasch, J.F., Lensen, R.P. & Bertina, R.M. (1997) Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance. Thrombosis and Haemostasis, 77, 252-257.
    • (1997) Thrombosis and Haemostasis , vol.77 , pp. 252-257
    • Guasch, J.F.1    Lensen, R.P.2    Bertina, R.M.3
  • 9
    • 0033779878 scopus 로고    scopus 로고
    • Genome-wide analysis of single-nucleotide polymorphisms in human expressed sequences
    • Irizarry, K., Kustanovich, V., Li, C., Brown, N., Nelson, S., Wong, W. & Lee, C.J. (2000) Genome-wide analysis of single-nucleotide polymorphisms in human expressed sequences. Nature Genetics, 26, 233-236.
    • (2000) Nature Genetics , vol.26 , pp. 233-236
    • Irizarry, K.1    Kustanovich, V.2    Li, C.3    Brown, N.4    Nelson, S.5    Wong, W.6    Lee, C.J.7
  • 12
    • 0028110027 scopus 로고
    • The mechanism of inactivation of human factor V and human factor Va by activated protein C
    • Kalafatis, M., Rand, M.D. & Mann, K.G. (1994) The mechanism of inactivation of human factor V and human factor Va by activated protein C. Journal of Biological Chemistry, 269, 31869-31880.
    • (1994) Journal of Biological Chemistry , vol.269 , pp. 31869-31880
    • Kalafatis, M.1    Rand, M.D.2    Mann, K.G.3
  • 13
    • 0027520285 scopus 로고
    • Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
    • Koster, T., Rosendaal, F.R., de Ronde, H., Briet, E., Vandenbroucke, J.P. & Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 342, 1503-1506.
    • (1993) Lancet , vol.342 , pp. 1503-1506
    • Koster, T.1    Rosendaal, F.R.2    De Ronde, H.3    Briet, E.4    Vandenbroucke, J.P.5    Bertina, R.M.6
  • 14
    • 0034053358 scopus 로고    scopus 로고
    • Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population
    • Le, W., Yu, J.D., Lu, L., Tao, R., You, B., Cai, X., Cao, W.J., Huang, W., He, R.M., Zhu, D.L., Chen, Z., & Gong, L.S. (2000) Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population. Clinical Genetics, 57, 296-303.
    • (2000) Clinical Genetics , vol.57 , pp. 296-303
    • Le, W.1    Yu, J.D.2    Lu, L.3    Tao, R.4    You, B.5    Cai, X.6    Cao, W.J.7    Huang, W.8    He, R.M.9    Zhu, D.L.10    Chen, Z.11    Gong, L.S.12
  • 15
    • 0029825271 scopus 로고    scopus 로고
    • Specificity of 'clotting' methods for factor V Leiden
    • Morse, C. & Standen, G. (1996) Specificity of 'clotting' methods for factor V Leiden. British Journal of Haematology, 95, 432-436.
    • (1996) British Journal of Haematology , vol.95 , pp. 432-436
    • Morse, C.1    Standen, G.2
  • 16
    • 0037100417 scopus 로고    scopus 로고
    • Functional characterization of recombinant FV Hong Kong and FV Cambridge
    • Norstrom, E., Thorelli, E. & Dahlback, B. (2002) Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood, 100, 524-530.
    • (2002) Blood , vol.100 , pp. 524-530
    • Norstrom, E.1    Thorelli, E.2    Dahlback, B.3
  • 18
    • 0028931717 scopus 로고
    • High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
    • Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. & Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 1504-1508.
    • (1995) Blood , vol.85 , pp. 1504-1508
    • Rosendaal, F.R.1    Koster, T.2    Vandenbroucke, J.P.3    Reitsma, P.H.4
  • 19
    • 0033561431 scopus 로고    scopus 로고
    • Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V
    • Thorelli, E., Kaufman, R.J. & Dahlback, B. (1999) Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood, 93, 2552-2558.
    • (1999) Blood , vol.93 , pp. 2552-2558
    • Thorelli, E.1    Kaufman, R.J.2    Dahlback, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.